Filter posts

BIO 2019 Innovation Zone Company Snapshot: HealthRhythms, Inc.

The next big medical breakthrough is on the horizon and all it takes is one …

BIO 2019 Innovation Zone Company Snapshot: Trellis Biosciences

The next big medical breakthrough is on the horizon and all it takes is one …

SEC Proposes Targeted Regulatory Relief for Certain Small Public Companies from Sarbanes-Oxley 404(b...

In a much-anticipated move, the Securities and Exchange Commission (SEC) recently proposed a rule to …

New BIO Report on Impact of Sarbanes-Oxley 404(b) on Emerging Biotech Innovators

BIO is out with a new report illustrating the negative impact of Sarbanes-Oxley 404(b) on …

You’re Invited: BIO Board Member to Discuss Challenges Facing Emerging Biotechs – and How to Fix...

Next week, MaxCyte CEO and Biotechnology Innovation Organization (BIO) Board Member Doug Doerfler will speak …

Save Money! Register Now for BIO Investor Forum - Early Bird Deadline is Wed, Aug 31

Don’t miss the opportunity to register early and get a discounted rate for the 2016 …

BIO Applauds House Passage of the Fostering Innovation Act

The House of Representatives has overwhelmingly passed the Fostering Innovation Act (H.R. 4139), a key …

BIO Welcomes Seven New Board Members

BIO elected seven new members to its Board of Directors, voted upon at this year’s …

Tick Size Pilot Program: A Few Pennies Make a Big Difference

Earlier this week, the Securities and Exchange Commission (SEC) approved a tick size pilot program …

Members of Congress Agree: Reg A+ Rules Need National Standard

We’ve written before about the importance of implementing Title IV of the JOBS Act (commonly …